{"filing":{"accession_number":"0001213900-26-081499","cik":"0001872529","ticker":"MDXH","company_name":"MDxHealth SA","form":"6-K","filing_date":"2026-07-24","report_date":"2026-07-24","primary_document":"ea0298615-6k_mdxhealth.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1872529/000121390026081499/ea0298615-6k_mdxhealth.htm"},"events":[{"id":20557,"run_id":18500,"accession_number":"0001213900-26-081499","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"MDxHealth received a Nasdaq notification on July 20, 2026, that it has failed to maintain the minimum market value of US$35 million required under Nasdaq Listing Rule 5550(b)(2). The company has 180 calendar days (until January 19, 2027) to regain compliance or faces potential delisting. This is a material disclosure of delisting risk under Item 3.01 equivalent, as it directly threatens the company's continued listing on Nasdaq Capital Market.","company_name":"MDxHealth SA","ticker":"MDXH","filing_date":"2026-07-24","form":"6-K","submitted_at":null,"items":[{"id":19945,"accession_number":"0001213900-26-081499","item_number":"EX-99.1","item_title":"ea029861501ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"MDxHealth received a Nasdaq notification on July 20, 2026, that it has failed to maintain the minimum market value of US$35 million required under Nasdaq Listing Rule 5550(b)(2). The company has 180 calendar days (until January 19, 2027) to regain compliance or faces potential delisting. This is a material disclosure of delisting risk under Item 3.01 equivalent, as it directly threatens the company's continued listing on Nasdaq Capital Market.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-24T21:29:37.459017+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19945,"accession_number":"0001213900-26-081499","item_number":"EX-99.1","item_title":"ea029861501ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"MDxHealth received a Nasdaq notification on July 20, 2026, that it has failed to maintain the minimum market value of US$35 million required under Nasdaq Listing Rule 5550(b)(2). The company has 180 calendar days (until January 19, 2027) to regain compliance or faces potential delisting. This is a material disclosure of delisting risk under Item 3.01 equivalent, as it directly threatens the company's continued listing on Nasdaq Capital Market.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-24T21:29:37.459017+00:00","company_name":"MDxHealth SA","ticker":"MDXH","filing_date":"2026-07-24"}]}